Clinical trial Epi-RCHOP
| Kankers | |
|---|---|
| Organ | Non-Hodgkin lymfoom |
| Trial status | Trial open voor rekrutering |
| Investigator(s) | |
| Trial type |
Interventioneel met experimenteel geneesmiddel
|
| Fase | Fase van de proef 1/2 |
| Academisch proef | Nee |
| Sponsor | Lysarc |
| EudraCT Identifier | 2016-001499-31 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT02889523 |
| Inclusion criteria | 1e lijn - DLBCL, getransformeerd, folliculair NHL graad IIIb |
| Laatste update |